Silvya Stuchi Maria-Engler

15PUBLICATIONS
74CO-AUTHORS
Gene and molecular therapyMolecular targetsLivestock cloningPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 27, 2025
Exploiting Paradoxical Activation of Oncogenic MAPK Signaling by Targeting Mitochondria to Sensitize NRAS Mutant-Melanoma to Vemurafenib.

Laura Francisca Leite do Prado-Souza, Letícia Silva Ferraz, Tharcísio Citrangulo Tortelli

|Jan 07, 2025
Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.

Diogo Dias, Erica Oliveira, Román Martí-Díaz

|May 25, 2024
Modeling Melanoma Heterogeneity In Vitro: Redox, Resistance and Pigmentation Profiles.

Larissa Anastacio da Costa Carvalho, Isabella Harumi Yonehara Noma, Adriana Hiromi Uehara

|Jul 29, 2023
2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) Inhibits Proliferation and Invasion via Senescence Pathway Induction in Human BRAFi-Resistant Melanoma Cells.

Ylana Adami Franco, Manoel Oliveira de Moraes, Larissa A C Carvalho

|Apr 13, 2023
Tissue Engineering Challenges for Cultivated Meat to Meet the Real Demand of a Global Market.

Andressa Cristina Antunes Santos, Denisse Esther Mallaupoma Camarena, Gustavo Roncoli Reigado

|Dec 23, 2022
3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells.

Patrik da Silva Vital, Murilo Bonatelli, Marina Pereira Dias

Pageof 3

Frequent Collaborators

3 joint publications

Wilson Araújo Silva Junior

2 joint publications

Larissa Anastacio da Costa Carvalho

2 joint publications

Erica Oliveira

2 joint publications

Tiago Rodrigues